| Unique ID issued by UMIN | UMIN000056104 |
|---|---|
| Receipt number | R000064100 |
| Scientific Title | Effect verification of a smartphone application to accelerate start and continuation of interval walking training |
| Date of disclosure of the study information | 2025/02/01 |
| Last modified on | 2024/11/15 09:17:22 |
Development of a smartphone application to accelerate popularization of interval walking training
Development of a smartphone application for interval walking training
Effect verification of a smartphone application to accelerate start and continuation of interval walking training
Effect verification of a smartphone application for interval walking training
| Japan |
lifestyle-related diseases and age-associated diseases
| Medicine in general | Geriatrics | Orthopedics |
| Rehabilitation medicine | Nursing | Adult |
Others
NO
To develop a smartphone application to accelerate start and continuation of interval walking training and to verify the effects.
Efficacy
1) The start rate of interval walking training
2) The continuation rate of interval walking training
1) Exercise volume
2) Exercise intensity
3) Physical characteristics (height, body weight, blood pressures)
4) Physical fitness (maximal aerobic capacity)
5) Blood composition
Interventional
Parallel
Randomized
Cluster
Single blind -participants are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Prevention
| Behavior,custom |
A group which uses a smartphone application equipped with programs to accelerate start and continuation of interval walking training as well as with that to record achievements of the training
A group which uses a smartphone application equipped with only program to record achievements of interval walking training
| 40 | years-old | <= |
| 80 | years-old | >= |
Male and Female
1) Those who are older than 40 yr or younger than 80 yr
2) Those who can walk with no help by others
3) Those who have not experienced interval walking training
4) Those who can use smartphone applications both for the plcebo and testing groups
5) Those who have given their informed consent to participate in the study after a full explanation by the investigators
1) Those who do not match any of the key inclusion criteria stated above.
2) Those who are judged as inappropriate subjects by the primary investigator
800
| 1st name | Shizue |
| Middle name | |
| Last name | Masuki |
Shinshu University
Graduate School of Medicine
390-8621
3-1-1 Asahi, Matsumoto, Nagano
0263-37-2682
masuki@shinshu-u.ac.jp
| 1st name | Shizue |
| Middle name | |
| Last name | Masuki |
Shinshu University
Graduate School of Medicine
390-8621
3-1-1 Asahi Matsumoto Nagano
0263-37-2682
masuki@shinshu-u.ac.jp
Shinshu University
Japan Agency for Medical Research and Development
Japanese Governmental office
Shinshu University School of Medicine, General Affairs Section
3-1-1 Asahi Matsumoto Nagano
0263-37-2527
mdrinri@shinshu-u.ac.jp
NO
| 2025 | Year | 02 | Month | 01 | Day |
Unpublished
Preinitiation
| 2024 | Year | 11 | Month | 07 | Day |
| 2024 | Year | 11 | Month | 07 | Day |
| 2025 | Year | 02 | Month | 01 | Day |
| 2029 | Year | 03 | Month | 31 | Day |
| 2024 | Year | 11 | Month | 08 | Day |
| 2024 | Year | 11 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064100